Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Human Somatotropin Market Growth 2022-2028

  • LP 4837816
  • 100 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Human Somatotropin will have significant change from previous year. According to our (LP Information) latest study, the global Human Somatotropin market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Human Somatotropin market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Human Somatotropin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Somatotropin market, reaching US$ million by the year 2028. As for the Europe Human Somatotropin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Human Somatotropin players cover Novo Nordisk, Pfizer, Eli Lilly, and Merck Serono, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Somatotropin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Powder

Solvent

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Growth Hormone Deficiency (GHD)

Turner Syndrome

Chronic Renal Insufficiency

Prader Willi Syndrome

Small for Gestational Age

SHOX Deficiency

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novo Nordisk

Pfizer

Eli Lilly

Merck Serono

F. Hoffmann-La Roche

Ferring Pharmaceuticals

GeneScience Pharmaceuticals

Ipsen

LG Life Sciences

Sandoz International

Anhui Anke Biotechnology

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Somatotropin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Somatotropin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Somatotropin by Country/Region, 2017, 2022 & 2028

2.2 Human Somatotropin Segment by Type

2.2.1 Powder

2.2.2 Solvent

2.3 Human Somatotropin Sales by Type

2.3.1 Global Human Somatotropin Sales Market Share by Type (2017-2022)

2.3.2 Global Human Somatotropin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Somatotropin Sale Price by Type (2017-2022)

2.4 Human Somatotropin Segment by Application

2.4.1 Growth Hormone Deficiency (GHD)

2.4.2 Turner Syndrome

2.4.3 Chronic Renal Insufficiency

2.4.4 Prader Willi Syndrome

2.4.5 Small for Gestational Age

2.4.6 SHOX Deficiency

2.4.7 Others

2.5 Human Somatotropin Sales by Application

2.5.1 Global Human Somatotropin Sale Market Share by Application (2017-2022)

2.5.2 Global Human Somatotropin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Somatotropin Sale Price by Application (2017-2022)

3 Global Human Somatotropin by Company

3.1 Global Human Somatotropin Breakdown Data by Company

3.1.1 Global Human Somatotropin Annual Sales by Company (2020-2022)

3.1.2 Global Human Somatotropin Sales Market Share by Company (2020-2022)

3.2 Global Human Somatotropin Annual Revenue by Company (2020-2022)

3.2.1 Global Human Somatotropin Revenue by Company (2020-2022)

3.2.2 Global Human Somatotropin Revenue Market Share by Company (2020-2022)

3.3 Global Human Somatotropin Sale Price by Company

3.4 Key Manufacturers Human Somatotropin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Somatotropin Product Location Distribution

3.4.2 Players Human Somatotropin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Somatotropin by Geographic Region

4.1 World Historic Human Somatotropin Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Somatotropin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Somatotropin Annual Revenue by Geographic Region

4.2 World Historic Human Somatotropin Market Size by Country/Region (2017-2022)

4.2.1 Global Human Somatotropin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Somatotropin Annual Revenue by Country/Region

4.3 Americas Human Somatotropin Sales Growth

4.4 APAC Human Somatotropin Sales Growth

4.5 Europe Human Somatotropin Sales Growth

4.6 Middle East & Africa Human Somatotropin Sales Growth

5 Americas

5.1 Americas Human Somatotropin Sales by Country

5.1.1 Americas Human Somatotropin Sales by Country (2017-2022)

5.1.2 Americas Human Somatotropin Revenue by Country (2017-2022)

5.2 Americas Human Somatotropin Sales by Type

5.3 Americas Human Somatotropin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Somatotropin Sales by Region

6.1.1 APAC Human Somatotropin Sales by Region (2017-2022)

6.1.2 APAC Human Somatotropin Revenue by Region (2017-2022)

6.2 APAC Human Somatotropin Sales by Type

6.3 APAC Human Somatotropin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Somatotropin by Country

7.1.1 Europe Human Somatotropin Sales by Country (2017-2022)

7.1.2 Europe Human Somatotropin Revenue by Country (2017-2022)

7.2 Europe Human Somatotropin Sales by Type

7.3 Europe Human Somatotropin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Somatotropin by Country

8.1.1 Middle East & Africa Human Somatotropin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Somatotropin Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Somatotropin Sales by Type

8.3 Middle East & Africa Human Somatotropin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Somatotropin

10.3 Manufacturing Process Analysis of Human Somatotropin

10.4 Industry Chain Structure of Human Somatotropin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Somatotropin Distributors

11.3 Human Somatotropin Customer

12 World Forecast Review for Human Somatotropin by Geographic Region

12.1 Global Human Somatotropin Market Size Forecast by Region

12.1.1 Global Human Somatotropin Forecast by Region (2023-2028)

12.1.2 Global Human Somatotropin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Somatotropin Forecast by Type

12.7 Global Human Somatotropin Forecast by Application

13 Key Players Analysis

13.1 Novo Nordisk

13.1.1 Novo Nordisk Company Information

13.1.2 Novo Nordisk Human Somatotropin Product Offered

13.1.3 Novo Nordisk Human Somatotropin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novo Nordisk Main Business Overview

13.1.5 Novo Nordisk Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Human Somatotropin Product Offered

13.2.3 Pfizer Human Somatotropin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Eli Lilly

13.3.1 Eli Lilly Company Information

13.3.2 Eli Lilly Human Somatotropin Product Offered

13.3.3 Eli Lilly Human Somatotropin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Eli Lilly Main Business Overview

13.3.5 Eli Lilly Latest Developments

13.4 Merck Serono

13.4.1 Merck Serono Company Information

13.4.2 Merck Serono Human Somatotropin Product Offered

13.4.3 Merck Serono Human Somatotropin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck Serono Main Business Overview

13.4.5 Merck Serono Latest Developments

13.5 F. Hoffmann-La Roche

13.5.1 F. Hoffmann-La Roche Company Information

13.5.2 F. Hoffmann-La Roche Human Somatotropin Product Offered

13.5.3 F. Hoffmann-La Roche Human Somatotropin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 F. Hoffmann-La Roche Main Business Overview

13.5.5 F. Hoffmann-La Roche Latest Developments

13.6 Ferring Pharmaceuticals

13.6.1 Ferring Pharmaceuticals Company Information

13.6.2 Ferring Pharmaceuticals Human Somatotropin Product Offered

13.6.3 Ferring Pharmaceuticals Human Somatotropin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Ferring Pharmaceuticals Main Business Overview

13.6.5 Ferring Pharmaceuticals Latest Developments

13.7 GeneScience Pharmaceuticals

13.7.1 GeneScience Pharmaceuticals Company Information

13.7.2 GeneScience Pharmaceuticals Human Somatotropin Product Offered

13.7.3 GeneScience Pharmaceuticals Human Somatotropin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 GeneScience Pharmaceuticals Main Business Overview

13.7.5 GeneScience Pharmaceuticals Latest Developments

13.8 Ipsen

13.8.1 Ipsen Company Information

13.8.2 Ipsen Human Somatotropin Product Offered

13.8.3 Ipsen Human Somatotropin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Ipsen Main Business Overview

13.8.5 Ipsen Latest Developments

13.9 LG Life Sciences

13.9.1 LG Life Sciences Company Information

13.9.2 LG Life Sciences Human Somatotropin Product Offered

13.9.3 LG Life Sciences Human Somatotropin Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 LG Life Sciences Main Business Overview

13.9.5 LG Life Sciences Latest Developments

13.10 Sandoz International

13.10.1 Sandoz International Company Information

13.10.2 Sandoz International Human Somatotropin Product Offered

13.10.3 Sandoz International Human Somatotropin Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Sandoz International Main Business Overview

13.10.5 Sandoz International Latest Developments

13.11 Anhui Anke Biotechnology

13.11.1 Anhui Anke Biotechnology Company Information

13.11.2 Anhui Anke Biotechnology Human Somatotropin Product Offered

13.11.3 Anhui Anke Biotechnology Human Somatotropin Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Anhui Anke Biotechnology Main Business Overview

13.11.5 Anhui Anke Biotechnology Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Human Somatotropin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Somatotropin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Powder

Table 4. Major Players of Solvent

Table 5. Global Human Somatotropin Sales by Type (2017-2022) & (MT)

Table 6. Global Human Somatotropin Sales Market Share by Type (2017-2022)

Table 7. Global Human Somatotropin Revenue by Type (2017-2022) & ($ million)

Table 8. Global Human Somatotropin Revenue Market Share by Type (2017-2022)

Table 9. Global Human Somatotropin Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Human Somatotropin Sales by Application (2017-2022) & (MT)

Table 11. Global Human Somatotropin Sales Market Share by Application (2017-2022)

Table 12. Global Human Somatotropin Revenue by Application (2017-2022)

Table 13. Global Human Somatotropin Revenue Market Share by Application (2017-2022)

Table 14. Global Human Somatotropin Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Human Somatotropin Sales by Company (2020-2022) & (MT)

Table 16. Global Human Somatotropin Sales Market Share by Company (2020-2022)

Table 17. Global Human Somatotropin Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Human Somatotropin Revenue Market Share by Company (2020-2022)

Table 19. Global Human Somatotropin Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Human Somatotropin Producing Area Distribution and Sales Area

Table 21. Players Human Somatotropin Products Offered

Table 22. Human Somatotropin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Human Somatotropin Sales by Geographic Region (2017-2022) & (MT)

Table 26. Global Human Somatotropin Sales Market Share Geographic Region (2017-2022)

Table 27. Global Human Somatotropin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Human Somatotropin Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Human Somatotropin Sales by Country/Region (2017-2022) & (MT)

Table 30. Global Human Somatotropin Sales Market Share by Country/Region (2017-2022)

Table 31. Global Human Somatotropin Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Human Somatotropin Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Human Somatotropin Sales by Country (2017-2022) & (MT)

Table 34. Americas Human Somatotropin Sales Market Share by Country (2017-2022)

Table 35. Americas Human Somatotropin Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Human Somatotropin Revenue Market Share by Country (2017-2022)

Table 37. Americas Human Somatotropin Sales by Type (2017-2022) & (MT)

Table 38. Americas Human Somatotropin Sales Market Share by Type (2017-2022)

Table 39. Americas Human Somatotropin Sales by Application (2017-2022) & (MT)

Table 40. Americas Human Somatotropin Sales Market Share by Application (2017-2022)

Table 41. APAC Human Somatotropin Sales by Region (2017-2022) & (MT)

Table 42. APAC Human Somatotropin Sales Market Share by Region (2017-2022)

Table 43. APAC Human Somatotropin Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Human Somatotropin Revenue Market Share by Region (2017-2022)

Table 45. APAC Human Somatotropin Sales by Type (2017-2022) & (MT)

Table 46. APAC Human Somatotropin Sales Market Share by Type (2017-2022)

Table 47. APAC Human Somatotropin Sales by Application (2017-2022) & (MT)

Table 48. APAC Human Somatotropin Sales Market Share by Application (2017-2022)

Table 49. Europe Human Somatotropin Sales by Country (2017-2022) & (MT)

Table 50. Europe Human Somatotropin Sales Market Share by Country (2017-2022)

Table 51. Europe Human Somatotropin Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Human Somatotropin Revenue Market Share by Country (2017-2022)

Table 53. Europe Human Somatotropin Sales by Type (2017-2022) & (MT)

Table 54. Europe Human Somatotropin Sales Market Share by Type (2017-2022)

Table 55. Europe Human Somatotropin Sales by Application (2017-2022) & (MT)

Table 56. Europe Human Somatotropin Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Human Somatotropin Sales by Country (2017-2022) & (MT)

Table 58. Middle East & Africa Human Somatotropin Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Human Somatotropin Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Human Somatotropin Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Human Somatotropin Sales by Type (2017-2022) & (MT)

Table 62. Middle East & Africa Human Somatotropin Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Human Somatotropin Sales by Application (2017-2022) & (MT)

Table 64. Middle East & Africa Human Somatotropin Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Human Somatotropin

Table 66. Key Market Challenges & Risks of Human Somatotropin

Table 67. Key Industry Trends of Human Somatotropin

Table 68. Human Somatotropin Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Human Somatotropin Distributors List

Table 71. Human Somatotropin Customer List

Table 72. Global Human Somatotropin Sales Forecast by Region (2023-2028) & (MT)

Table 73. Global Human Somatotropin Sales Market Forecast by Region

Table 74. Global Human Somatotropin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Human Somatotropin Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Human Somatotropin Sales Forecast by Country (2023-2028) & (MT)

Table 77. Americas Human Somatotropin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Human Somatotropin Sales Forecast by Region (2023-2028) & (MT)

Table 79. APAC Human Somatotropin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Human Somatotropin Sales Forecast by Country (2023-2028) & (MT)

Table 81. Europe Human Somatotropin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Human Somatotropin Sales Forecast by Country (2023-2028) & (MT)

Table 83. Middle East & Africa Human Somatotropin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Human Somatotropin Sales Forecast by Type (2023-2028) & (MT)

Table 85. Global Human Somatotropin Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Human Somatotropin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Human Somatotropin Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Human Somatotropin Sales Forecast by Application (2023-2028) & (MT)

Table 89. Global Human Somatotropin Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Human Somatotropin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Human Somatotropin Revenue Market Share Forecast by Application (2023-2028)

Table 92. Novo Nordisk Basic Information, Human Somatotropin Manufacturing Base, Sales Area and Its Competitors

Table 93. Novo Nordisk Human Somatotropin Product Offered

Table 94. Novo Nordisk Human Somatotropin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. Novo Nordisk Main Business

Table 96. Novo Nordisk Latest Developments

Table 97. Pfizer Basic Information, Human Somatotropin Manufacturing Base, Sales Area and Its Competitors

Table 98. Pfizer Human Somatotropin Product Offered

Table 99. Pfizer Human Somatotropin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Pfizer Main Business

Table 101. Pfizer Latest Developments

Table 102. Eli Lilly Basic Information, Human Somatotropin Manufacturing Base, Sales Area and Its Competitors

Table 103. Eli Lilly Human Somatotropin Product Offered

Table 104. Eli Lilly Human Somatotropin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Eli Lilly Main Business

Table 106. Eli Lilly Latest Developments

Table 107. Merck Serono Basic Information, Human Somatotropin Manufacturing Base, Sales Area and Its Competitors

Table 108. Merck Serono Human Somatotropin Product Offered

Table 109. Merck Serono Human Somatotropin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. Merck Serono Main Business

Table 111. Merck Serono Latest Developments

Table 112. F. Hoffmann-La Roche Basic Information, Human Somatotropin Manufacturing Base, Sales Area and Its Competitors

Table 113. F. Hoffmann-La Roche Human Somatotropin Product Offered

Table 114. F. Hoffmann-La Roche Human Somatotropin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. F. Hoffmann-La Roche Main Business

Table 116. F. Hoffmann-La Roche Latest Developments

Table 117. Ferring Pharmaceuticals Basic Information, Human Somatotropin Manufacturing Base, Sales Area and Its Competitors

Table 118. Ferring Pharmaceuticals Human Somatotropin Product Offered

Table 119. Ferring Pharmaceuticals Human Somatotropin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Ferring Pharmaceuticals Main Business

Table 121. Ferring Pharmaceuticals Latest Developments

Table 122. GeneScience Pharmaceuticals Basic Information, Human Somatotropin Manufacturing Base, Sales Area and Its Competitors

Table 123. GeneScience Pharmaceuticals Human Somatotropin Product Offered

Table 124. GeneScience Pharmaceuticals Human Somatotropin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. GeneScience Pharmaceuticals Main Business

Table 126. GeneScience Pharmaceuticals Latest Developments

Table 127. Ipsen Basic Information, Human Somatotropin Manufacturing Base, Sales Area and Its Competitors

Table 128. Ipsen Human Somatotropin Product Offered

Table 129. Ipsen Human Somatotropin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 130. Ipsen Main Business

Table 131. Ipsen Latest Developments

Table 132. LG Life Sciences Basic Information, Human Somatotropin Manufacturing Base, Sales Area and Its Competitors

Table 133. LG Life Sciences Human Somatotropin Product Offered

Table 134. LG Life Sciences Human Somatotropin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 135. LG Life Sciences Main Business

Table 136. LG Life Sciences Latest Developments

Table 137. Sandoz International Basic Information, Human Somatotropin Manufacturing Base, Sales Area and Its Competitors

Table 138. Sandoz International Human Somatotropin Product Offered

Table 139. Sandoz International Human Somatotropin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 140. Sandoz International Main Business

Table 141. Sandoz International Latest Developments

Table 142. Anhui Anke Biotechnology Basic Information, Human Somatotropin Manufacturing Base, Sales Area and Its Competitors

Table 143. Anhui Anke Biotechnology Human Somatotropin Product Offered

Table 144. Anhui Anke Biotechnology Human Somatotropin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 145. Anhui Anke Biotechnology Main Business

Table 146. Anhui Anke Biotechnology Latest Developments

List of Figures

Figure 1. Picture of Human Somatotropin

Figure 2. Human Somatotropin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Somatotropin Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Human Somatotropin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Somatotropin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Powder

Figure 10. Product Picture of Solvent

Figure 11. Global Human Somatotropin Sales Market Share by Type in 2021

Figure 12. Global Human Somatotropin Revenue Market Share by Type (2017-2022)

Figure 13. Human Somatotropin Consumed in Growth Hormone Deficiency (GHD)

Figure 14. Global Human Somatotropin Market: Growth Hormone Deficiency (GHD) (2017-2022) & (MT)

Figure 15. Human Somatotropin Consumed in Turner Syndrome

Figure 16. Global Human Somatotropin Market: Turner Syndrome (2017-2022) & (MT)

Figure 17. Human Somatotropin Consumed in Chronic Renal Insufficiency

Figure 18. Global Human Somatotropin Market: Chronic Renal Insufficiency (2017-2022) & (MT)

Figure 19. Human Somatotropin Consumed in Prader Willi Syndrome

Figure 20. Global Human Somatotropin Market: Prader Willi Syndrome (2017-2022) & (MT)

Figure 21. Human Somatotropin Consumed in Small for Gestational Age

Figure 22. Global Human Somatotropin Market: Small for Gestational Age (2017-2022) & (MT)

Figure 23. Human Somatotropin Consumed in SHOX Deficiency

Figure 24. Global Human Somatotropin Market: SHOX Deficiency (2017-2022) & (MT)

Figure 25. Human Somatotropin Consumed in Others

Figure 26. Global Human Somatotropin Market: Others (2017-2022) & (MT)

Figure 27. Global Human Somatotropin Sales Market Share by Application (2017-2022)

Figure 28. Global Human Somatotropin Revenue Market Share by Application in 2021

Figure 29. Human Somatotropin Revenue Market by Company in 2021 ($ Million)

Figure 30. Global Human Somatotropin Revenue Market Share by Company in 2021

Figure 31. Global Human Somatotropin Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global Human Somatotropin Revenue Market Share by Geographic Region in 2021

Figure 33. Global Human Somatotropin Sales Market Share by Region (2017-2022)

Figure 34. Global Human Somatotropin Revenue Market Share by Country/Region in 2021

Figure 35. Americas Human Somatotropin Sales 2017-2022 (MT)

Figure 36. Americas Human Somatotropin Revenue 2017-2022 ($ Millions)

Figure 37. APAC Human Somatotropin Sales 2017-2022 (MT)

Figure 38. APAC Human Somatotropin Revenue 2017-2022 ($ Millions)

Figure 39. Europe Human Somatotropin Sales 2017-2022 (MT)

Figure 40. Europe Human Somatotropin Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Human Somatotropin Sales 2017-2022 (MT)

Figure 42. Middle East & Africa Human Somatotropin Revenue 2017-2022 ($ Millions)

Figure 43. Americas Human Somatotropin Sales Market Share by Country in 2021

Figure 44. Americas Human Somatotropin Revenue Market Share by Country in 2021

Figure 45. United States Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC Human Somatotropin Sales Market Share by Region in 2021

Figure 50. APAC Human Somatotropin Revenue Market Share by Regions in 2021

Figure 51. China Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 55. India Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe Human Somatotropin Sales Market Share by Country in 2021

Figure 58. Europe Human Somatotropin Revenue Market Share by Country in 2021

Figure 59. Germany Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 60. France Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa Human Somatotropin Sales Market Share by Country in 2021

Figure 65. Middle East & Africa Human Somatotropin Revenue Market Share by Country in 2021

Figure 66. Egypt Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country Human Somatotropin Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of Human Somatotropin in 2021

Figure 72. Manufacturing Process Analysis of Human Somatotropin

Figure 73. Industry Chain Structure of Human Somatotropin

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390